{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:06:35Z","timestamp":1791389195820,"version":"4.3.3"},"reference-count":171,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2019.00065","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T05:32:42Z","timestamp":1553837562000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":89,"title":["Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies"],"prefix":"10.3389","volume":"12","author":[{"given":"Marta","family":"Cenciarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Belia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Sforna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ronchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"D\u2019Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Pessia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1158\/0008-5472.can-04-4283","article-title":"EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma","volume":"65","author":"Alaminos","year":"2005","journal-title":"Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/s0028-3843(14)60408-4","article-title":"The role of the PTEN gene in malignant gliomas","volume":"44","author":"Alexiou","year":"2010","journal-title":"Neurol. Neurochir. Pol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2174\/156800909788166637","article-title":"Hypoxia helps glioma to fight therapy","volume":"9","author":"Amberger-Murphy","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"B4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.canlet.2009.12.006","article-title":"Suberoylanilide hydroxamic acid limits migration and invasion of glioma cells in two and three dimensional culture","volume":"292","author":"An","year":"2010","journal-title":"Cancer Lett."},{"key":"B5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1023\/A:1006319417077","article-title":"Effects of radiation on a model of malignant glioma invasion","volume":"44","author":"Bauman","year":"1999","journal-title":"J. Neurooncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/cancers3010461","article-title":"Extra-neural metastases of malignant gliomas: myth or reality?","volume":"3","author":"Beauchesne","year":"2011","journal-title":"Cancers"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.biocel.2004.01.013","article-title":"Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion","volume":"36","author":"Bellail","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s12032-014-0985-5","article-title":"Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience","volume":"31","author":"Bezecny","year":"2014","journal-title":"Med. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/02841850600580598","article-title":"Potential of diffusion imaging in brain tumors: a review","volume":"47","author":"Bode","year":"2006","journal-title":"Acta Radiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/jnnp.63.4.520","article-title":"The case of the disappearing glioma","volume":"63","author":"Buxton","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.arcmed.2014.11.018","article-title":"Role of the blood-brain barrier in the nutrition of the central nervous system","volume":"45","author":"Campos-Bedolla","year":"2014","journal-title":"Arch. Med. Res."},{"key":"B204","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fncel.2015.00152","article-title":"Reconciling the discrepancies on the involvement of large-conductance Ca2+-activated K channels in glioblastoma cell migration","volume":"9","author":"Catacuzzeno","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00232-013-9609-9","article-title":"Identification of key signaling molecules involved in the activation of the swelling-activated chloride current in human glioblastoma cells","volume":"247","author":"Catacuzzeno","year":"2014","journal-title":"J. Membr. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejphar.2017.05.064","article-title":"The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme","volume":"810","author":"Chistiakov","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.ajpath.2015.02.023","article-title":"Molecular and genomic alterations in glioblastoma multiforme","volume":"185","author":"Crespo","year":"2015","journal-title":"Am. J. Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrn3765","article-title":"A neurocentric perspective on glioma invasion","volume":"15","author":"Cuddapah","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"11188","DOI":"10.1074\/jbc.M109.097675","article-title":"Molecular interaction and functional regulation of ClC-3 by Ca2+\/calmodulin-dependent protein kinase II (CaMKII) in human malignant glioma","volume":"285","author":"Cuddapah","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5114\/wo.2018.73893","article-title":"Clinical and immunological correlates of long term survival in glioblastoma","volume":"22","author":"Czapski","year":"2018","journal-title":"Contemp. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.2174\/0929867324666170713103621","article-title":"Functional roles of the Ca2+-activated K+ channel, KCa3.1, in brain tumors","volume":"16","author":"D\u2019Alessandro","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1476-4598-3-36","article-title":"Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities","volume":"3","author":"Das","year":"2004","journal-title":"Mol. Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/07357900701788080","article-title":"Modulatory effects of acetazolomide and dexamethasone on temozolomide-mediated apoptosis in human glioblastoma T98G and U87MG cells","volume":"26","author":"Das","year":"2008","journal-title":"Cancer Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1200\/JCO.2011.37.5873","article-title":"Virchow 2011 or how to ID(H) human glioblastoma","volume":"29","author":"DeAngelis","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1586\/ecp.11.1","article-title":"Corticosteroids in brain cancer patients: benefits and pitfalls","volume":"4","author":"Dietrich","year":"2011","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009","volume":"14","author":"Dolecek","year":"2012","journal-title":"Neuro Oncol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2018.09.002","article-title":"Epigenetic modulation of metabolism in glioblastoma","author":"Dong","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11060-018-2761-4","article-title":"Dexamethasone-induced leukocytosis is associated with poor survival in newly diagnosed glioblastoma","volume":"137","author":"Dubinski","year":"2018","journal-title":"J. Neurooncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fncel.2014.00418","article-title":"Gliomas and the vascular fragility of the blood brain barrier","volume":"8","author":"Dubois","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e93264","DOI":"10.1371\/journal.pone.0093264","article-title":"Dexamethasone alleviates tumor-associated brain damage and angiogenesis","volume":"9","author":"Fan","year":"2014","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1006\/bbrc.1995.1356","article-title":"Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor","volume":"208","author":"Finkenzeller","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1172\/JCI41004","article-title":"The therapeutic promise of the cancer stem cell concept","volume":"120","author":"Frank","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B34","first-page":"1383","article-title":"Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas","volume":"60","author":"Frederick","year":"2000","journal-title":"Cancer Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1101\/gad.1596707","article-title":"Malignant astrocytic glioma: genetics, biology and paths to treatment","volume":"21","author":"Furnari","year":"2007","journal-title":"Genes Dev."},{"key":"B36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1242\/jcs.109.2.429","article-title":"Overexpression of occludin, a tight junction-associated integral membrane protein, induces the formation of intracellular multilamellar bodies bearing tight junction-like structures","volume":"109","author":"Furuse","year":"1996","journal-title":"J. Cell Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1083\/jcb.123.6.1777","article-title":"Occludin: a novel integral membrane protein localizing at tight junctions","volume":"123","author":"Furuse","year":"1993","journal-title":"J. Cell Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1083\/jcb.143.2.391","article-title":"A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts","volume":"143","author":"Furuse","year":"1998","journal-title":"J. Cell Biol."},{"key":"B39","first-page":"46","article-title":"Use of dexamethasone in treatment of cerebral oedema associated with brain tumors","volume":"81","author":"Galicich","year":"1961","journal-title":"J. Lancet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jocn.2008.10.029","article-title":"Vanishing glioblastoma after corticosteroid therapy","volume":"16","author":"Goh","year":"2009","journal-title":"J. Clin. Neurosci."},{"key":"B206","first-page":"585","article-title":"Combined growth-inhibitory responses and ultrastructural alterations produced by 1,3-bis(2-chloroethyl)-1-nitrosourea and dexamethasone in rat glioma cell cultures","volume":"37","author":"Grasso","year":"1977","journal-title":"Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"59360","DOI":"10.18632\/oncotarget.10661","article-title":"Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells","volume":"7","author":"Grinshtein","year":"2016","journal-title":"Oncotarget"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1158\/1078-0432.CCR-11-0774","article-title":"Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide","volume":"17","author":"Grossman","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neulet.2008.12.047","article-title":"The molecular mechanism of dexamethasone-mediated effect on the blood-brain tumor barrier permeability in a rat brain tumor model","volume":"452","author":"Gu","year":"","journal-title":"Neurosci. Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2008.12.080","article-title":"Dexamethasone enhances calcium-activated potassium channel expression in blood-brain tumor barrier in a rat brain tumor model","volume":"1259","author":"Gu","year":"","journal-title":"Brain Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2007.05.053","article-title":"Dexamethasone enhances adenosine 5\u2032-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model","volume":"1162","author":"Gu","year":"2007","journal-title":"Brain Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"7595","DOI":"10.3892\/ol.2018.8269","article-title":"Effects of dexamethasone on C6 cell proliferation, migration and invasion through the upregulation of AQP1","volume":"15","author":"Guan","year":"2018","journal-title":"Oncol. Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.410310504","article-title":"Vascular differentiation and glucose transporter expression in rat gliomas: effects of steroids","volume":"31","author":"Guerin","year":"1992","journal-title":"Ann. Neurol."},{"key":"B48","first-page":"4251","article-title":"Glucocorticoids augment survival and proliferation of tumor cells","volume":"32","author":"G\u00fcndisch","year":"2012","journal-title":"Anticancer Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21037\/cco.2017.06.11","article-title":"Isocitrate dehydrogenase mutation as a therapeutic target in gliomas","volume":"6","author":"Han","year":"2017","journal-title":"Chin. Clin. Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.ajpath.2012.06.030","article-title":"Mechanisms of glioma-associated neovascularization","volume":"181","author":"Hardee","year":"2012","journal-title":"Am. J. Pathol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00401-009-0561-9","article-title":"Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age:a study of 1,010 diffuse gliomas","volume":"118","author":"Hartmann","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/sj.bjc.6605551","article-title":"Hypoxia inducible factors in cancer stem cells","volume":"102","author":"Heddleston","year":"2010","journal-title":"Br. J. Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/bf00691870","article-title":"The effect of dexamethasone on serum protein extravasation and oedema development in experimental brain tumors of cat","volume":"60","author":"Hossmann","year":"1983","journal-title":"Acta Neuropathol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"re6","DOI":"10.1126\/scisignal.287re6","article-title":"Oncogenic EGFR signaling networks in glioma","volume":"2","author":"Huang","year":"2009","journal-title":"Sci. Signal"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/jcbfm.2015.38","article-title":"Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein","volume":"35","author":"Hue","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ijrobp.2004.12.085","article-title":"Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection","volume":"62","author":"Hughes","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B57","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11060-009-9827-2","article-title":"Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression and as a therapeutic target","volume":"92","author":"Jensen","year":"2009","journal-title":"J. Neurooncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.cco.0000142076.52721.b3","article-title":"The management of brain oedema in brain tumors","volume":"16","author":"Kaal","year":"2004","journal-title":"Curr. Opin. Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0006-291X(03)00167-0","article-title":"Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3","volume":"302","author":"Kale","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-018-01061-5","article-title":"Predictive markers for MGMT promoter methylation in glioblastomas","author":"Kanazawa","year":"2019","journal-title":"Neurosurg. Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1023\/A:1010684921099","article-title":"Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone","volume":"51","author":"Kaup","year":"2001","journal-title":"J. Neurooncol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/156720208783565645","article-title":"Blood brain barrier in hypoxic-ischemic conditions","volume":"5","author":"Kaur","year":"2008","journal-title":"Curr. Neurovasc. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bbrc.2008.05.025","article-title":"Dexamethasone coordinately regulates angiopoietin-1 and VEGF: a mechanism of glucocorticoid-induced stabilization of blood-brain barrier","volume":"372","author":"Kim","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1750-3639.1998.tb00192.x","article-title":"Subsets of glioblastoma: clinical and histological vs","volume":"8","author":"Kleihues","year":"1998","journal-title":"Brain Pathol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.3747\/co.21.1769","article-title":"Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline","volume":"21","author":"Kostaras","year":"2014","journal-title":"Curr. Oncol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/s0960-9822(99)80452-7","article-title":"Ca2+-independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions","volume":"9","author":"Kubota","year":"1999","journal-title":"Curr. Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1620\/tjem.168.265","article-title":"Overexpression and amplification of \u03b1-PDGF receptor gene lacking exons coding for a portion of the extracellular region in a malignant glioma","volume":"168","author":"Kumabe","year":"1992","journal-title":"Tohoku J. Exp. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.pjnns.2018.03.002","article-title":"The evaluation of the effects of steroid treatment on the tumor and peritumoral oedema by DWI and MR spectroscopy in brain tumors","volume":"52","author":"Kural","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/jnr.490310316","article-title":"Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone","volume":"31","author":"Langeveld","year":"1992","journal-title":"J. Neurosci. Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"E166","DOI":"10.3390\/brainsci7120166","article-title":"Advances in brain tumor surgery for glioblastoma in adults","volume":"7","author":"Lara-Velazquez","year":"2017","journal-title":"Brain Sci."},{"key":"B72","first-page":"615","article-title":"Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy","volume":"35","author":"Lee","year":"2015","journal-title":"Anticancer Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"18577","DOI":"10.18632\/oncotarget.14612","article-title":"Advances in epigenetic glioblastoma therapy","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"B71","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.semcancer.2018.07.006","article-title":"Comparison of glioblastoma (GBM) molecular classification methods","volume":"53","author":"Lee","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"14615","DOI":"10.1074\/jbc.C112.353946","article-title":"Cancer associated isocitrate dehydrogenase mutations inactivate NADPH-dependent reductive carboxylation","volume":"287","author":"Leonardi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"33440","DOI":"10.18632\/oncotarget.7961","article-title":"PI3K\/Akt\/mTOR signaling pathway and targeted therapy for glioblastoma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"B201","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","article-title":"Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells","volume":"15","author":"Li","year":"2009","journal-title":"Cancer Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s004010000180","article-title":"Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme","volume":"100","author":"Liebner","year":"2000","journal-title":"Acta Neuropathol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2009.01.050","article-title":"Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line","volume":"1265","author":"Liu","year":"2009","journal-title":"Brain Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2008.06.111","article-title":"Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1(MKP-1) dependent mechanism","volume":"593","author":"Lin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.steroids.2016.02.019","article-title":"New dimension of glucocorticoids in cancer treatment","volume":"111","author":"Lin","year":"2016","journal-title":"Steroids"},{"key":"B77","doi-asserted-by":"publisher","first-page":"69051","DOI":"10.18632\/oncotarget.12053","article-title":"The role of cerebral blood flow gradient in peritumoral oedema for differentiation of glioblastomas from solitary metastatic lesions","volume":"7","author":"Lin","year":"2016","journal-title":"Oncotarget"},{"key":"B81","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3171\/2017.7.jns17668","article-title":"Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma","volume":"129","author":"Luedi","year":"2018","journal-title":"J. Neurosurg."},{"key":"B83","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/ANA.0000000000000368","article-title":"A dexamethasone-regulated gene signature is prognostic for poor survival in glioblastoma patients","volume":"29","author":"Luedi","year":"2017","journal-title":"J. Neurosurg. Anesthesiol."},{"key":"B84","first-page":"4515","article-title":"Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3","volume":"30","author":"Lui","year":"2010","journal-title":"Anticancer Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"9463","DOI":"10.1158\/0008-5472.can-07-2034","article-title":"Autocrine glutamate signaling promotes glioma cell invasion","volume":"67","author":"Lyons","year":"2007","journal-title":"Cancer Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1046\/j.1365-2990.1999.00166.x","article-title":"Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells","volume":"25","author":"Machein","year":"1999","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"viii1","DOI":"10.1093\/neuonc\/nou294","article-title":"Molecular pathologic diagnosis of epidermal growth factor receptor","volume":"16","author":"Maire","year":"2014","journal-title":"Neuro Oncol."},{"key":"B88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"B89","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nbd.2009.12.030","article-title":"The DNA methylome of glioblastoma multiforme","volume":"39","author":"Martinez","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B207","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3171\/jns.1971.34.3.0324","article-title":"Effects of dexamethasone and methylprednisolone on cell cultures of human glioblastomas","volume":"34","author":"Mealey","year":"1971","journal-title":"J. Neurosurg."},{"key":"B90","first-page":"853","article-title":"Molecular genetic analysis of giant cell glioblastomas","volume":"151","author":"Meyer-Puttlitz","year":"1997","journal-title":"Am. J. Pathol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"9949","DOI":"10.3390\/ijms16059949","article-title":"Pathogenesis of brain oedema and investigation into anti-oedema drugs","volume":"16","author":"Michinaga","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1043\/1543-2165(2007)131[397:G]2.0.CO;2","article-title":"Glioblastoma","volume":"131","author":"Miller","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1523\/JNEUROSCI.3825-10.2011","article-title":"Bradykinin promotes the chemotactic invasion of primary brain tumors","volume":"31","author":"Montana","year":"2011","journal-title":"J. Neurosci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/s0006-8993(98)01093-2","article-title":"Dexamethasone enhances serum deprivation-induced necrotic death of rat C6 glioma cells through activation of glucocorticoid receptors","volume":"816","author":"Morita","year":"1999","journal-title":"Brain Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/labinvest.3700325","article-title":"Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown","volume":"85","author":"Nag","year":"2005","journal-title":"Lab. Invest."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.2741\/1016","article-title":"The role of matrix metalloproteinases in glioma invasion","volume":"8","author":"Nakada","year":"2003","journal-title":"Front. Biosci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/carcin\/22.10.1715","article-title":"Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C \u2013>A:T mutations of the TP53 tumor suppressor gene","volume":"22","author":"Nakamura","year":"2001","journal-title":"Carcinogenesis"},{"key":"B98","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/s0014-2999(97)01464-7","article-title":"Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells","volume":"341","author":"Nauck","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10014-010-0007-z","article-title":"Angiogenesis and invasion in glioma","volume":"28","author":"Onishi","year":"2011","journal-title":"Brain Tumor Pathol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3171\/jns.1999.90.2.0300","article-title":"Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors","volume":"90","author":"Ostergaard","year":"1999","journal-title":"J. Neurosurg."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.4161\/21645515.2014.983002","article-title":"The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients","volume":"10","author":"Paff","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.neuroscience.2004.05.044","article-title":"Molecular mechanisms of brain tumor oedema","volume":"129","author":"Papadopoulos","year":"2004","journal-title":"Neuroscience"},{"key":"B103","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1046\/j.0305-1846.2001.00341.x","article-title":"Occludin expression in microvessels of neoplastic and non-neoplastic human brain","volume":"27","author":"Papadopoulos","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10059-009-0111-2","article-title":"Biology of glioma cancer stem cells","volume":"28","author":"Park","year":"2009","journal-title":"Mol. Cells"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"B106","doi-asserted-by":"publisher","first-page":"32483","DOI":"10.1074\/jbc.m109.014589","article-title":"The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors","volume":"284","author":"Piette","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B107","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-006-0100-x","article-title":"Treating gliomas with glucocorticoids: from bedside to bench","volume":"112","author":"Piette","year":"2006","journal-title":"Acta Neuropathol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1210\/jcem.77.5.8077338","article-title":"Inhibition of growth of the human malignant glioma cell line (U87MG) by the steroid hormone antagonist RU486","volume":"77","author":"Pinski","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/brain\/aww046","article-title":"Corticosteroids compromise survival in glioblastoma","volume":"139","author":"Pitter","year":"2016","journal-title":"Brain"},{"key":"B109","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2014.03.024","article-title":"SWELL1, a plasma membrane protein, is an essential component of volume-regulated anion channel","volume":"157","author":"Qiu","year":"2014","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","first-page":"14344","DOI":"10.1073\/pnas.0507200102","article-title":"Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas","volume":"102","author":"Rand","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B111","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc1121","article-title":"Molecular mechanisms of glioma invasiveness: the role of proteases","volume":"3","author":"Rao","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"B112","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"B113","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3389\/fonc.2018.00448","article-title":"Epigenetic targeting of glioblastoma","volume":"8","author":"Romani","year":"2018","journal-title":"Front. Oncol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/00005072-200606000-00001","article-title":"\u2018Pseudopalisading\u2019 necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis","volume":"65","author":"Rong","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/jcp.25592","article-title":"Overexpression of large-conductance calcium-activated potassium channels in human glioblastoma stem-like cells and their role in cell migration","volume":"232","author":"Rosa","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1126\/science.1171837","article-title":"The increasing complexity of the cancer stem cell paradigm","volume":"324","author":"Rosen","year":"2009","journal-title":"Science"},{"key":"B117","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev.neuro.22.1.11","article-title":"The cell biology of the blood-brain barrier","volume":"22","author":"Rubin","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fonc.2018.00142","article-title":"Downregulation of leucine-rich repeat-containing 8A limits proliferation and increases sensitivity of glioblastoma to temozolomide and carmustine","volume":"8","author":"Rubino","year":"2018","journal-title":"Front. Oncol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1023\/b:neon.0000024241.05346.24","article-title":"CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells","volume":"67","author":"Salmaggi","year":"2004","journal-title":"J. Neurooncol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00441-013-1762-z","article-title":"Glucocorticoids and endothelial cell barrier function","volume":"355","author":"Salvador","year":"2014","journal-title":"Cell Tissue Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fncel.2014.00467","article-title":"The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma","volume":"8","author":"Sforna","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/jcp.25393","article-title":"Hypoxia modulates the swelling-activated Cl current in human glioblastoma cells: role in volume regulation and cell survival","volume":"232","author":"Sforna","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2217\/14796694.4.4.525","article-title":"Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas","volume":"4","author":"Shai","year":"2008","journal-title":"Future Oncol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13014-015-0527-0","article-title":"Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients","volume":"10","author":"Shields","year":"2015","journal-title":"Radiat. Oncol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/bf00146880","article-title":"The cause of death in patients with glioblastoma is multifactorial: clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults","volume":"10","author":"Silbergeld","year":"1991","journal-title":"J. Neurooncol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1136\/jnnp.2003.028647","article-title":"Effects of dexamethasone on peritumoral oedematous brain: a DT-MRI study","volume":"75","author":"Sinha","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B127","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00109-013-1019-z","article-title":"Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme","volume":"91","author":"Soda","year":"2013","journal-title":"J. Mol. Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13402-016-0301-9","article-title":"Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine","volume":"40","author":"Staberg","year":"2017","journal-title":"Cell. Oncol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/13543784.2016.1182497","article-title":"Investigational new drugs for brain cancer","volume":"25","author":"Staedtke","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B130","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1177\/0271678X15617172","article-title":"Molecular pathophysiology of cerebral oedema","volume":"36","author":"Stokum","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B131","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12032-018-1083-x","article-title":"Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment","volume":"35","author":"Stoyanov","year":"2018","journal-title":"Med. Oncol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e0131670","DOI":"10.1371\/journal.pone.0131670","article-title":"A potential role for the inhibition of PI3K signaling in glioblastoma therapy","volume":"10","author":"Str\u00f6bele","year":"2015","journal-title":"PLoS One"},{"key":"B133","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/foc.2007.22.5.9","article-title":"Mechanisms of tumor-related brain oedema","volume":"22","author":"Stummer","year":"2007","journal-title":"Neurosurg. Focus"},{"key":"B134","doi-asserted-by":"publisher","first-page":"188","DOI":"10.18632\/oncoscience.315","article-title":"Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments","volume":"3","author":"Sundahl","year":"2016","journal-title":"Oncoscience"},{"key":"B135","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/glia.20168","article-title":"Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells","volume":"50","author":"Sur","year":"2005","journal-title":"Glia"},{"key":"B136","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1054\/jocn.2000.0817","article-title":"The effects of dexamethasone therapy on permeability, blood flow and iNOS expression in experimental glioma","volume":"8","author":"Swaroops","year":"2001","journal-title":"J. Clin. Neurosci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"351908","DOI":"10.1155\/2010\/351908","article-title":"Molecular therapeutic targets for glioma angiogenesis","volume":"2010","author":"Takano","year":"2010","journal-title":"J. Oncol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1038\/sj.onc.1210297","article-title":"Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumors with allelic losses on 1p and 19q","volume":"26","author":"Tews","year":"2007","journal-title":"Oncogene"},{"key":"B139","doi-asserted-by":"publisher","first-page":"20130095","DOI":"10.1098\/rstb.2013.0095","article-title":"Cl\u2212 and K+ channels and their role in primary brain tumor biology","volume":"369","author":"Turner","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B140","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell."},{"key":"B141","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc1889","article-title":"Brain tumor stem cells","volume":"6","author":"Vescovi","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"B142","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1750-3639.2008.00139.x","article-title":"Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment","volume":"18","author":"Villeneuve","year":"2008","journal-title":"Brain Pathol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1126\/science.1252826","article-title":"Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC","volume":"344","author":"Voss","year":"2014","journal-title":"Science"},{"key":"B144","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/neuonc\/nov136","article-title":"Isocitrate dehydrogenase mutations in gliomas","volume":"18","author":"Waitkus","year":"2016","journal-title":"Neuro Oncol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2009.01.019","article-title":"Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma","volume":"279","author":"Wang","year":"2009","journal-title":"Cancer Lett."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1158\/1078-0432.ccr-0829-3","article-title":"Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy","volume":"10","author":"Wang","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"63788","DOI":"10.18632\/oncotarget.19093","article-title":"Suppression of CLC-3 chloride channel reduces the aggressiveness of glioma through inhibiting nuclear factor-\u03baB pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"B148","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13148-018-0598-5","article-title":"Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells","volume":"11","author":"Was","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"B149","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/07357900500449546","article-title":"Methylated tumor-specific DNA as a plasma biomarker in patients with glioma","volume":"24","author":"Weaver","year":"2006","journal-title":"Cancer Invest."},{"key":"B151","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1212\/01.con.0000464172.50638.21","article-title":"Medical management of patients with brain tumors","volume":"80","author":"Wen","year":"2006","journal-title":"J. Neurooncol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","article-title":"Tight junctions of the blood-brain barrier: development, composition and regulation","volume":"38","author":"Wolburg","year":"2002","journal-title":"Vascul Pharmacol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1055\/s-2008-1043962","article-title":"Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo","volume":"209","author":"Wolff","year":"1997","journal-title":"Klin. Padiatr."},{"key":"B155","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/jcp.25891","article-title":"Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion","volume":"233","author":"Wong","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.mam.2012.02.003","article-title":"The disturbed blood-brain barrier in human glioblastoma","volume":"33","author":"Wolburg","year":"2012","journal-title":"Mol. Aspects. Med."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/bjc.2015.404","article-title":"Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma","volume":"113","author":"Wong","year":"2015","journal-title":"Br. J. Cancer"},{"key":"B156","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11060-011-0604-7","article-title":"Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures","volume":"105","author":"Xu","year":"2011","journal-title":"J. Neurooncol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1016\/j.ejrad.2011.10.018","article-title":"Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment","volume":"81","author":"Yamasaki","year":"2012","journal-title":"Eur. J. Radiol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1172\/JCI83871","article-title":"Cancer immunotherapy: harnessing the immune system to battle cancer","volume":"125","author":"Yang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B159","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.yexcr.2012.07.017","article-title":"Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications","volume":"318","author":"Yang","year":"2012","journal-title":"Exp. Cell Res."},{"key":"B160","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.3892\/mmr.2017.8265","article-title":"Association of aquaporin\u20141 with tumor migration, invasion and vasculogenic mimicry in glioblastoma multiforme","volume":"17","author":"Yang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B158","doi-asserted-by":"publisher","first-page":"38444","DOI":"10.18632\/oncotarget.16461","article-title":"Effects of AQP5 gene silencing on proliferation, migration and apoptosis of human glioma cells through regulating EGFR\/ERK\/ p38 MAPK signalling pathway","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"B162","first-page":"4383","article-title":"Glioma cells release excitotoxic concentrations of glutamate","volume":"59","author":"Ye","year":"1999","journal-title":"Cancer Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.gene.2015.09.080","article-title":"Functional roles of enhancer of zeste homolog 2 in gliomas","volume":"576","author":"Yin","year":"2016","journal-title":"Gene"},{"key":"B164","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00701-004-0282-8","article-title":"Vanishing contrastenhancement in malignant glioma after corticosteroid treatment","volume":"146","author":"Zaki","year":"2004","journal-title":"Acta Neurochir."},{"key":"B165","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainres.2007.01.133","article-title":"Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5\u2019-triphosphate-sensitive potassium channel","volume":"1144","author":"Zhang","year":"2007","journal-title":"Brain Res."},{"key":"B166","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-017-0670-3","article-title":"Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol. Cancer"},{"key":"B167","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2007.10.099","article-title":"Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in vitro","volume":"1189","author":"Zozulya","year":"2008","journal-title":"Brain Res."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T15:15:02Z","timestamp":1663168502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":171,"alternative-id":["10.3389\/fnmol.2019.00065"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2019.00065","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]},"article-number":"65"}}